[Federal Register Volume 69, Number 115 (Wednesday, June 16, 2004)]
[Notices]
[Pages 33665-33666]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-13537]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By notice dated October 7, 2003, and published in the Federal 
Register on October 29, 2003, (68 FR 61699), Guilford Pharmaceuticals, 
Inc., 6611 Tributary Street, Baltimore, Maryland 21224, made 
application by renewal to the Drug Enforcement Administration

[[Page 33666]]

for registration as a bulk manufacturer of Cocaine (9041), a basic 
class of controlled substance listed in Schedule II.
    The firm plans to manufacture a Schedule II cocaine derivative as a 
final intermediate for the production of dopascan injection.
    No comments or objections have been received. DEA has considered 
the factors in title 21, United States Code, section 823(a) and 
determined that the registration of Guilford Pharmaceuticals, Inc. to 
manufacture the listed controlled substance is consistent with the 
public interest at this time. DEA has investigated Guilford 
Pharmaceuticals, Inc. to ensure that the company's registration is 
consistent with the public interest. This investigation has included 
inspection and testing of the company's physical security systems, 
verification of the company's compliance with state and local laws, and 
a review of the company's background and history. Therefore, pursuant 
to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy Assistant 
Administrator, Office of Diversion Control, hereby orders that the 
application submitted by the above firm for registration as a bulk 
manufacturer of the basic class of controlled substance listed is 
granted.

    Dated: May 26, 2004.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 04-13537 Filed 6-15-04; 8:45 am]
BILLING CODE 4410-09-M